Innovation
We’re still figuring out the side effects of GLP-1 weight-loss drugs
MIT Technology Review
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age. Overweight and diabetic people who take GLP-1s have a biological age around two to three years younger than similar…
Read the full story at the original publisher
MIT Technology Review →
-
The Download: failed social media bans, and extending pets’ livesMIT Technology Review18 hours ago
-
Can’t bear to say goodbye to your pet? Biotech’s got you covered.MIT Technology Review21 hours ago
-
Love is infrastructureMIT Technology Review21 hours ago
Leave a Reply